Efficacy of recombinant human deoxyribonuclease (Rh-DNase) in infants hospitalised with respiratory syncytial virus bronchiolitis: a multicentre randomised double-blind clinical trial

R. Boogaard, A. R. Hulsmann, W. C. J. Hop, P. J. F. M. Merkus, the Dnase-RSV Study Group (Rotterdam, Breda, Netherlands)

Source: Annual Congress 2006 - Bronchiolitis in infancy, treatment and outcome
Session: Bronchiolitis in infancy, treatment and outcome
Session type: Oral Presentation
Number: 4365
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Boogaard, A. R. Hulsmann, W. C. J. Hop, P. J. F. M. Merkus, the Dnase-RSV Study Group (Rotterdam, Breda, Netherlands). Efficacy of recombinant human deoxyribonuclease (Rh-DNase) in infants hospitalised with respiratory syncytial virus bronchiolitis: a multicentre randomised double-blind clinical trial. Eur Respir J 2006; 28: Suppl. 50, 4365

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High-dose inhaled corticosteroids prevent wheeze following respiratory syncytial virus infection: a randomized double-blind placebo-controlled trial
Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology
Year: 2008

Recombinant human deoxyribonuclease (rhDNase) for the treatment of acute asthma in children: a multicentre randomised double-blind clinical trial
Source: Annual Congress 2007 - Childhood asthma: treatment and follow-up
Year: 2007


Results of a phase 2b multi-center, randomized, double-blind, placebo-controlled study of an RNAi therapeutic, ALN-RSV01, in respiratory syncytial virus (RSV)-infected lung transplant patients
Source: Annual Congress 2012 - Novel approaches to lung transplantation
Year: 2012

Effectiveness of influenza vaccination in asthmatic children: randomised, double-blind, placebo-controlled trial
Source: Eur Respir J 2002; 20: Suppl. 38, 146s
Year: 2002

Double-blind placebo controlled randomized trial of montelukast in acute RSV bronchiolitis
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007


Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial
Source: Eur Respir J 2007; 29: 91-97
Year: 2007



Randomized controlled trial of chest physiotherapy in infants with viral acute bronchiolitis
Source: International Congress 2017 – Assessing and targeting functional outcomes in respiratory physiotherapy
Year: 2017




Helium-oxygen gas mixtures in infants with acute bronchiolitis: results of a phase III double-blind, multicentre RCT
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009

Inhaled racemic adrenalin versus saline in acute bronchiolitis, a multicenter randomized double-blind clinical trial
Source: Annual Congress 2012 - New insights into respiratory infections in children
Year: 2012

Antibiotic in non-purulent hospitalised-treated exacerbations of COPD: a randomised double-blind placebo-controlled trial
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

The results of a randomized clinical trial of the efficacy of the antibodies-based drug in influenza and acute respiratory viral infections in children
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019


LATE-BREAKING ABSTRACT: Results of a phase 2b multi-center trial of ALN-RSV01 in respiratory syncytial virus (RSV)-infected lung transplant patients
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012

RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



A randomized, controlled, open-label study to evaluate the efficacy and safety of oral lopinavir-ritonavir in adults hospitalized with COVID-19 virus infection
Source: Virtual Congress 2020 – Chinese programme 2020: Part I
Year: 2020


Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)
Source: ERJ Open Res, 8 (1) 00610-2021; 10.1183/23120541.00610-2021
Year: 2022



A phase-III multicenter, randomized, double-blind, controlled trial of high-dose inhaled nitric oxide in infants with acute bronchiolitis.
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018


Azithromycin and Hydroxychloroquine in hospitalized patients with confirmed SARS-CoV-2 infection - a randomized placebo-controlled trial (ProPAC-COVID Trial)
Source: Virtual Congress 2021 – COVID - 19 treatments
Year: 2021


Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
Source: Eur Respir J, 59 (2) 2101471; 10.1183/13993003.01471-2021
Year: 2022



Effect of high dose inhaled beclomethasone for respiratory syncytial virus bronchiolitis during infancy on lung function and asthma at age 6 – A randomised placebo-controlled trial
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013


Epidemiology of severe respiratory syncytial virus infection in Ethiopian infants : A prospective study
Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum
Year: 2020